Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Metabolism: Clinical and Experimental|January 17, 2016
Metformin-associated lactic acidosis: Current perspectives on causes and riskRalph DeFronzo, G Alexander Fleming, Kim Chen, et al.American Journal of Clinical Oncology|May 2, 2012
Predicting acute and persistent neuropathy associated with oxaliplatinLinh M Alejandro, Carolyn E Behrendt, Kim Chen, et al.The Journal of Clinical Endocrinology and Metabolism|May 17, 2007
Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation studyLouis Aronne, Ken Fujioka, Vanita Aroda, et al.International Journal of Pharmaceutics|February 23, 2008
Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administrationBronislava R Gedulin, Pamela A Smith, Carolyn M Jodka, et al.Obesity (Silver Spring, Md.)|May 15, 2007
Low-dose pramlintide reduced food intake and meal duration in healthy, normal-weight subjectsIan Chapman, Barbara Parker, Selena Doran, et al.Diabetes Care|October 8, 2009
Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetesKristina I Rother, Lisa M Spain, Robert A Wesley, et al.Pageof 1